Transfusion‐transmitted malaria in Europe and North America: Epidemiology, residual risk and implications for blood safety policies
Vox Sanguinis · 09.11.2026
DOI: 10.1111/vox.70389 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vox Sanguinis, online erschienen am 09.11.2026. Verfasst von Massimo La Raja und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion Medicine, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives Transfusion‐transmitted malaria (TTM) is a rare but potentially severe transfusion complication. Increasing global mobility from malaria‐endemic regions challenges donor selection policies in non‐endemic settings, as asymptomatic parasitaemia may persist for years in previously exposed semi‐immune individuals. This review aims to contextualise the residual risk of TTM and critically appraise current and past preventive strategies considering available evidence, with particular attention to policy implications. Materials and Methods A literature review of all confirmed cases of TTM reported in Europe and North America between 2005 and 2024 was performed to retrospectively assess the effectiveness and limitations of past and current preventive strategies, with particular reference to the recommendations of the European Directorate for the Quality of Medicines & HealthCare (EDQM) Blood Guide and the U.S. Food and Drug Administration (FDA).
Results
Eighteen confirmed TTM cases were identified: 11 by Plasmodium falciparum with three fatalities, six by Plasmodium malariae and one by Plasmodium ovale . Sixteen cases were linked to donors born in or long‐term residents of malaria‐endemic regions, predominantly sub‐Saharan Africa; two involved short‐term European travellers. Since 2012, no P. falciparum TTM cases have been reported in Europe following the correct implementation of EDQM guidelines.
Conclusion
The residual risk of TTM in Europe and North America appears to be extremely low. However, long‐term asymptomatic carriers—particularly of P. falciparum —remain a potential threat. Approaches based on deferral and immunological testing appeared to be effective and sustainable; nevertheless, high‐sensitivity nucleic acid testing may represent a valuable alternative, particularly where blood availability is critical.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Transfusion Medicine, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.
- Centro Nazionale Sangue, Istituto Superiore di Sanità, Rome, Italy.
- European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, Strasbourg, France.
- Faculty of Medical Sciences, University Goce Delcev, Stip, North Macedonia.
- Blood Transfusion Service of Southern Switzerland SRC, Lugano, Switzerland.
- Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
ORCID-Profile: Massimo La Raja, Rada Milos Grubovic Rastvorceva, Øystein Flesland, Betina Samuelsen Sørensen
Zitieren
APA
La Raja, M., Grubovic Rastvorceva, R. M., Fontana, S., Pink, J., Tinguely, C., Flesland, Ø., & Sørensen, B. S. (2026). Transfusion‐transmitted malaria in Europe and North America: Epidemiology, residual risk and implications for blood safety policies. Vox Sanguinis. https://doi.org/10.1111/vox.70389
Vancouver
La Raja M, Grubovic Rastvorceva RM, Fontana S, Pink J, Tinguely C, Flesland Ø, et al. Transfusion‐transmitted malaria in Europe and North America: Epidemiology, residual risk and implications for blood safety policies. Vox Sanguinis. 2026. doi:10.1111/vox.70389
BibTeX
@article{LaRaja2026,
author = {La Raja, Massimo and Grubovic Rastvorceva, Rada Milos and Fontana, Stefano and Pink, Joanne and Tinguely, Caroline and Flesland, Øystein and Sørensen, Betina Samuelsen},
title = {Transfusion‐transmitted malaria in Europe and North America: Epidemiology, residual risk and implications for blood safety policies},
journal = {Vox Sanguinis},
year = {2026},
doi = {10.1111/vox.70389}
}
EUVIMED